The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Open accessAbstract
Background & Aims Magnetic-resonance-imaging (MRI) techniques and ultrasound-based transient elastography (TE) can be used in noninvasive diagnosis of fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD). We performed a prospective study to compare the performance of magnetic resonance elastography (MRE) vs TE for in diagnosis of fibrosis, and MRI-based proton density fat fraction (MRI-PDFF) analysis vs TE-based controlled attenuation parameter (CAP) for diagnosis of steatosis in patients undergoing biopsy to assess NAFLD. Methods We performed a cross-sectional study of 104 consecutive adults (56.7% female) who underwent MRE, TE, and liver biopsy analysis (using the histological scoring system for NAFLD from the nonalcoholic steatohepatitis clinical research network scoring system) from October 2011 through May 2016 at a tertiary medical center. All patients received a standard clinical evaluation, including collection of history, anthropometric examination, and biochemical tests. The primary outcomes were fibrosis and steatosis. Secondary outcomes included dichotomized stages of fibrosis and NASH vs no NASH. Receiver operating characteristic (ROC) curve analyses were used to compare performances of MRE vs TE in diagnosis of fibrosis (stages 1–4 vs 0) and MRI-PDFF vs CAP for diagnosis of steatosis (grades 1–3 vs 0) with respect to findings from biopsy analysis. Results MRE detected any fibrosis (stage 1 or more) with an area under the ROC (AUROC) of 0.82 (95% CI, 0.74–0.91), which was significantly higher than that of TE (AUROC, 0.67; 95% CI, 0.56–0.78). MRI-PDFF detected any steatosis with an AUROC of 0.99 (95% CI, 0.98–1.00), which was significantly higher that of CAP (AUROC, 0.85; 95% CI, 0.75–0.96). MRE detected fibrosis of stages 2, 3, or 4 with AUROC values of 0.89 (95% CI, 0.83–0.96), 0.87 (95% CI, 0.78–0.96), and 0.87 (95% CI, 0.71-1.00); TE detected fibrosis of stages 2, 3, or 4 with AUROC values of 0.86 (95% CI, 0.77–0.95), 0.80 (95% CI, 0.67–0.93), and 0.69 (95% CI, 0.45–0.94). MRI-PDFF identified steatosis of grades 2 or 3 with AUROC values of 0.90 (95% CI, 0.82–0.97) and 0.92 (95% CI, 0.84–0.99); CAP identified steatosis of grades 2 or 3 with AUROC values of 0.70 (95% CI, 0.58–0.82) and 0.73 (95% CI, 0.58–0.89). Conclusions In a prospective, cross-sectional study of more than 100 patients, we found MRE to be more accurate than TE in identification of liver fibrosis (stage 1 or more), using biopsy analysis as the standard. MRI-PDFF is more accurate than CAP in detecting all grades of steatosis in patients with NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
Sandrin, L., Fourquet, B., Hasquenoph, J.-M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.07.001 · Cited by 2,738
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Self-citationWilliams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Self-citationPerformance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Friedrich–Rust, M., Ong, M., Martens, S., Sarrazin, C., Bojunga, J., Zeuzem, S., & Herrmann, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.034 · Cited by 1,490
Non-invasive evaluation of liver fibrosis using transient elastography
Castera, L., Forns, X., & Alberti, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.008 · Cited by 1,430
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Yin, M., Talwalkar, J. A., Glaser, K. J., Manduca, A., Grimm, R. C., Rossman, P. J., Fidler, J. L., & Ehman, R. L. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.012 · Cited by 948
Sasso, M., Beaugrand, M., de Ledinghen, V., Douvin, C., Marcellin, P., Poupon, R., Sandrin, L., & Miette, V. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.07.005 · Cited by 862
Fraquelli, M., Rigamonti, C., Casazza, G., Conte, D., Donato, M. F., Ronchi, G., & Colombo, M. (2007) · Gut · doi:10.1136/gut.2006.111302 · Cited by 854
Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.048 · Cited by 812
Magnetic Resonance Elastography for the Noninvasive Staging of Liver Fibrosis
Huwart, L., Sempoux, C., Vicaut, E., Salameh, N., Annet, L., Danse, E., Peeters, F., ter Beek, L. C., Rahier, J., Sinkus, R., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.076 · Cited by 731
Coco, B., Oliveri, F., Maina, A. M., Ciccorossi, P., Sacco, R., Colombatto, P., Bonino, F., & Brunetto, M. R. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00811.x · Cited by 662
Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 659
Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Castera, L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.017 · Cited by 605
Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis
Millonig, G., Reimann, F. M., Friedrich, S., Fonouni, H., Mehrabi, A., Büchler, M. W., Seitz, H. K., & Mueller, S. (2008) · Hepatology · doi:10.1002/hep.22577 · Cited by 599
Noureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550
Self-citationTang, A., Tan, J., Sun, M., Hamilton, G., Bydder, M., Wolfson, T., Gamst, A. C., Middleton, M., Brunt, E. M., Loomba, R., et al. (2013) · Radiology · doi:10.1148/radiol.12120896 · Cited by 528
Self-citationLoomba, R., Wolfson, T., Ang, B., Hooker, J., Behling, C., Peterson, M., Valasek, M., Lin, G., Brenner, D., Gamst, A., et al. (2014) · Hepatology · doi:10.1002/hep.27362 · Cited by 489
Self-citationThe natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
Loomba, R., Schork, N., Chen, C.-H., Bettencourt, R., Bhatt, A., Ang, B., Nguyen, P., Hernandez, C., Richards, L., Salotti, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.011 · Cited by 389
Self-citationFoucher, J., Cast??ra, L., Bernard, P.-H., Adhoute, X., Laharie, D., Bertet, J., Couzigou, P., & de L??dinghen, V. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200604000-00015 · Cited by 382
de Lédinghen, V., Vergniol, J., Capdepont, M., Chermak, F., Hiriart, J.-B., Cassinotto, C., Merrouche, W., Foucher, J., & Brigitte, L. B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.018 · Cited by 379
Tang, A., Desai, A., Hamilton, G., Wolfson, T., Gamst, A., Lam, J., Clark, L., Hooker, J., Chavez, T., Ang, B. D., et al. (2015) · Radiology · doi:10.1148/radiol.14140754 · Cited by 356
Self-citationDulai, P. S., Sirlin, C. B., & Loomba, R. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.005 · Cited by 356
Self-citationPermutt, Z., Le, T. ‐., Peterson, M. R., Seki, E., Brenner, D. A., Sirlin, C., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05121.x · Cited by 346
Self-citationLiver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, A. W.-H., Chermak, F., Choi, P. C.-L., Merrouche, W., Chu, S. H.-T., Pesque, S., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.331 · Cited by 345
Loomba, R., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J., Kono, Y., Bhatt, A., et al. (2015) · Hepatology · doi:10.1002/hep.27647 · Cited by 344
Self-citationMyers, R. P., Pollett, A., Kirsch, R., Pomier‐Layrargues, G., Beaton, M., Levstik, M., Duarte‐Rojo, A., Wong, D., Crotty, P., & Elkashab, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02781.x · Cited by 343
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Cui, J., Philo, L., Nguyen, P., Hofflich, H., Hernandez, C., Bettencourt, R., Richards, L., Salotti, J., Bhatt, A., Hooker, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.021 · Cited by 326
Self-citationMerriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 324
de Lédinghen, V., Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chu, S. H.-T., Le Bail, B., Choi, P. C.-L., Chermak, F., Yiu, K. K.-L., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.017 · Cited by 244
Le, T.-A., Chen, J., Changchien, C., Peterson, M. R., Kono, Y., Patton, H., Cohen, B. L., Brenner, D., Sirlin, C., & Loomba, R. (2012) · Hepatology · doi:10.1002/hep.25731 · Cited by 243
Self-citationNon‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
Doycheva, I., Cui, J., Nguyen, P., Costa, E. A., Hooker, J., Hofflich, H., Bettencourt, R., Brouha, S., Sirlin, C. B., & Loomba, R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13405 · Cited by 210
Self-citationLoomba, R., Cui, J., Wolfson, T., Haufe, W., Hooker, J., Szeverenyi, N., Ang, B., Bhatt, A., Wang, K., Aryafar, H., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.65 · Cited by 202
Self-citationCui, J., Heba, E., Hernandez, C., Haufe, W., Hooker, J., Andre, M. P., Valasek, M. A., Aryafar, H., Sirlin, C. B., & Loomba, R. (2016) · Hepatology · doi:10.1002/hep.28337 · Cited by 191
Self-citationChan, W., Nik Mustapha, N. R., & Mahadeva, S. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12557 · Cited by 180
Patel, J., Bettencourt, R., Cui, J., Salotti, J., Hooker, J., Bhatt, A., Hernandez, C., Nguyen, P., Aryafar, H., Valasek, M., et al. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16656735 · Cited by 163
Self-citationCui, J. Y., Ang, B., Haufe, W. M., Hernandez, C., Verna, E. C., Sirlin, C. B., & Loomba, R. S. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13196 · Cited by 162
Self-citationBonekamp, S., Tang, A., Mashhood, A., Wolfson, T. J., Changchien, C., Middleton, M. S., Clark, L., Gamst, A. C., Loomba, R. S., & Sirlin, C. B. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24321 · Cited by 130
Self-citationElastography for Detecting Hepatic Fibrosis: Options and Considerations
Talwalkar, J. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.038 · Cited by 81
Pavlov, C. S., Casazza, G., Nikolova, D., Tsochatzis, E. A., & Gluud, C. N. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13524 · Cited by 69
(1950) · doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
Cited by
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Self-citationBerzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
“%) were more likely to have NASH resolution (41% vs 7%, p<0.001; OR 5.45, 95% CI 1.53-19.46, p=0.009) compared to MRI-PDFF non-responders.”
InfluentialGinès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Self-citation
Metadata
- Authors
- Park, C. C., Nguyen, P., Hernandez, C., Bettencourt, R., Ramirez, K., Fortney, L., Hooker, J., Sy, E., Savides, M. T., Alquiraish, M. H., Valasek, M. A., Rizo, E., Richards, L., Brenner, D., Sirlin, C. B., & Loomba, R.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 152
- Issue
- 3
- Pages
- 598-607.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2546306361
- Cited by
- 708
- References
- 51
- FWCI
- 46.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.